Beyaz and Depression - a phase IV clinical study of FDA data

Summary:

Depression is reported as a side effect among people who take Beyaz (drospirenone; ethinyl estradiol; levomefolate calcium), especially for people who are female, 20-29 old, have been taking the drug for 1 - 6 months also take Yaz, and have Polycystic ovary disease.

The phase IV clinical study analyzes which people have Depression when taking Beyaz. It is created by eHealthMe based on reports of 1,929 people who have side effects when taking Beyaz from the FDA, and is updated regularly.

What is Beyaz?

Beyaz has active ingredients of drospirenone; ethinyl estradiol; levomefolate calcium. It is often used in birth control. eHealthMe is studying from 2,012 Beyaz users. Check the latest studies of Beyaz.

What is Depression?

Depression is found to be associated with 3,168 drugs and 4,127 conditions by eHealthMe. Check the latest studies of Depression.

On Aug, 04, 2026

1,929 people reported to have side effects when taking Beyaz.
Among them, 42 people (2.18%) have Depression.

Among these 42 people:

How long have people been on Beyaz when they have Depression? *

What is the gender of people who have Depression when taking Beyaz? *

female: 97.62 %
male: 2.38 %

What is the age of people who have Depression when taking Beyaz? *

What are other drugs people take besides Beyaz? *

What are other side effects people have besides Depression? *

Injury: 17 people, 40.48%
Emotional Distress: 15 people, 35.71%
Stress And Anxiety: 14 people, 33.33%
Pain: 14 people, 33.33%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 8 people, 19.05%
Nervousness: 7 people, 16.67%
Pulmonary Embolism (blockage of the main artery of the lung): 6 people, 14.29%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 6 people, 14.29%
Headache (pain in head): 5 people, 11.90%
Speech Disorder: 5 people, 11.90%

What are the existing conditions these people have? *

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 4.76%
Menstruation Irregular: 2 people, 4.76%
Heavy Or Prolong Menstrual Bleeding: 2 people, 4.76%
Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 2 people, 4.76%
Indigestion: 1 person, 2.38%
Hyperchlorhydria (gastric acid levels are higher in stomach): 1 person, 2.38%
High Blood Pressure: 1 person, 2.38%
Gonorrhea (a common human sexually transmitted infection caused by the bacterium neisseria gonorrhoea): 1 person, 2.38%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 2.38%
Weight Loss: 1 person, 2.38%

* Approximation only. Some reports may have incomplete information.

Do you take Beyaz and have Depression?

- Check whether Depression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Beyaz:

Beyaz (2,012 reports)

Depression treatments and more:

Depression (652,152 reports)

How severe was Depression and when was it recovered:

Depression in Beyaz

Expand to all the drugs that have ingredients of drospirenone; ethinyl estradiol; levomefolate calcium:

Depression and drugs with ingredients of drospirenone; ethinyl estradiol; levomefolate calcium (46 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Beyaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Depression:

Depression (3,168 drugs)

Browse all the conditions that are associated with Depression:

Depression (4,127 conditions)

Related publications that referenced our studies

Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on drospirenone; ethinyl estradiol; levomefolate calcium (the active ingredients of Beyaz) and Beyaz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.